Table 1.
Time period and data sparsity by type of cancer
| Cancer type | Total diagnoses | Number of SA2s with 0 counts | Number of SA2s with 0 people at risk 2006–2014 | ||||
|---|---|---|---|---|---|---|---|
| M | F | P | M | F | P | ||
| 2010–2014 | |||||||
| All cancers C00–C97, D45, D46, D47.1, D47.3–D47.5 | 615,192 | 29 | 42 | 26 | 21 | 31 | 18 |
| Bowel cancer (C18–C20) | 74,223 | 71 | 88 | 61 | 60 | 74 | 48 |
| Lung cancer (C33–C34) | 54,792 | 90 | 115 | 74 | 71 | 91 | 64 |
| Melanoma of the skin (C43) | 61,310 | 95 | 110 | 73 | 74 | 88 | 42 |
| Breast cancera (C50) | 77,992 | – | 62 | – | – | 46 | – |
| Prostate cancerb (C61) | 99,681 | 57 | – | – | 41 | – | – |
| 2005–2014 | |||||||
| Head and neck cancer (C00–C14, C30–C32) | 40,441 | 72 | 211 | 67 | 73 | 223 | 67 |
| Oesophageal cancer (C15) | 13,362 | 252 | 700 | 170 | 264 | 751 | 177 |
| Stomach cancer (C16) | 20,084 | 192 | 433 | 139 | 201 | 476 | 146 |
| Liver cancer (C22) | 14,985 | 244 | 660 | 172 | 264 | 728 | 186 |
| Pancreatic cancer (C25) | 26,939 | 162 | 223 | 103 | 176 | 253 | 106 |
| Cervical cancera (C53) | 7930 | – | 302 | – | – | 308 | – |
| Uterine cancera (C54–C55) | 22,020 | – | 101 | – | – | 105 | – |
| Ovarian cancera (C56) | 13,267 | – | 199 | – | – | 211 | – |
| Kidney cancer (C64) | 28,212 | 114 | 248 | 91 | 116 | 252 | 92 |
| Brain cancer (C71) | 14,933 | 255 | 392 | 156 | 269 | 418 | 165 |
| Thyroid cancer (C73) | 21,895 | 443 | 189 | 123 | 452 | 192 | 125 |
| Non-Hodgkin lymphoma (C82–C86) | 45,169 | 96 | 146 | 71 | 96 | 152 | 71 |
| Myeloma (C90) | 15,264 | 279 | 431 | 172 | 294 | 456 | 182 |
| Leukaemia (C91–C95) | 30,737 | 124 | 200 | 88 | 134 | 217 | 91 |
M males, F females, P persons
a Females only
b Males only note that only the 2148 SA2s considered to have a residential population are included